Bolivia, Plurinational State of vs Congo: Average cost of multi drug-resistant tuberculosis treatment
Bolivia, Plurinational State of
753 constant 2022 US$
in 2024
Congo
726 constant 2022 US$
in 2024
Bolivia, Plurinational State of rank
65th
Congo rank
66th
Average cost of multi drug-resistant tuberculosis treatment over time
- Bolivia, Plurinational State of
- Congo
How they compare
Bolivia, Plurinational State of currently reports 753 constant 2022 US$ against 726 constant 2022 US$ in Congo, a difference of 27 constant 2022 US$.
The two have swapped places 4 times across 6 shared years of data; in 2017 it was Bolivia, Plurinational State of ahead.
Bolivia, Plurinational State of ranks 65th and Congo ranks 66th of 92 countries.
Across the 2 decades both report, Bolivia, Plurinational State of averaged higher in 1 and Congo in 1.
Head to head by decade
| Decade | Bolivia, Plurinational State of | Congo | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2,506 constant 2022 US$ | 1,793 constant 2022 US$ | 713.67 constant 2022 US$ | Bolivia, Plurinational State of |
| 2020s | 717.33 constant 2022 US$ | 785 constant 2022 US$ | 67.67 constant 2022 US$ | Congo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average cost of multi drug-resistant tuberculosis treatment, Bolivia, Plurinational State of or Congo?
- Bolivia, Plurinational State of, at 753 constant 2022 US$ against 726 constant 2022 US$ in Congo as of 2024.
- What is the difference in average cost of multi drug-resistant tuberculosis treatment between Bolivia, Plurinational State of and Congo?
- 27 constant 2022 US$, with Bolivia, Plurinational State of ahead.
- How many years of comparable data are there for Bolivia, Plurinational State of and Congo?
- 6 years are reported by both, from 2017 to 2024.
- How do Bolivia, Plurinational State of and Congo rank globally for average cost of multi drug-resistant tuberculosis treatment?
- Bolivia, Plurinational State of ranks 65th and Congo ranks 66th of 92 countries.
- Where does this data come from?
- WHO (2025) – with minor processing by Our World in Data, published as Average cost of multi drug-resistant tuberculosis treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Average cost of drugs spent per patient starting multidrug-resistant tuberculosis treatment, excluding buffer stock.